Citation Impact

3 by Nobel laureates 67 standout
Sub-graph 1 of 22

Citing Papers

Renal cell carcinoma
2024 Standout
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
2023 Standout
3 intermediate papers

Works of D.Y.C. Heng being referenced

Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc)
2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
2014
and 2 more

Author Peers

Author PRM Cancer Research Oncology Molecular Biology Last Decade Papers Cites
D.Y.C. Heng 628 306 362 387 54 896
S Ziaei Rad 10 404
Dinesh Kumar Singhal 2 2 59 12 388
E.A. Gross 216 239 61 200 21 1.2k
Jinyang Zeng 2 8 31 50 24 317
Louise Crabtree 19 23 344

All Works

Loading papers...

Rankless by CCL
2026